BETA-LACTAMASE INHIBITORS

Course overview

BETA-LACTAMASE INHIBITORS ARE DRUGS THAT ARE CO-ADMINISTERED WITH BETA-LACTAM ANTIMICROBIALS TO PREVENT ANTIMICROBIAL RESISTANCE BY INHIBITING SERINE BETA-LACTAMASES, WHICH ARE ENZYMES THAT INACTIVATE THE BETA-LACTAM RING, WHICH IS A COMMON CHEMICAL STRUCTURE TO ALL BETA-LACTAM ANTIMICROBIALS. THIS ACTIVITY OUTLINES THE DIFFERENT TYPES OF BETA-LACTAMASE INHIBITORS. IT DISCUSSES THE PHARMACOLOGICAL PROPERTIES OF BETA-LACTAMASE INHIBITORS, THEIR MEDICAL USES, METHODS OF ADMINISTRATION, SIDE EFFECTS, AND OTHER PROPERTIES. IT ALSO HIGHLIGHTS THE CRITICAL ROLE THAT PROVIDERS PLAY IN TERMS OF CORRECTLY ADMINISTERING BETA-LACTAMASE INHIBITORS IN COMBINATION WITH BETA-LACTAM ANTIMICROBIALS AND COUNSELING PATIENTS REGARDING MEDICATION ADHERENCE.